Salivary diagnostics in pediatrics: Applicability, translatability, and limitations

Frontiers in Public Health

Volumn 5, Issue APR, 2017, Pages

  Hassaneen, Mona ^a   Maron, Jill L ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Diagnostics; Genetics; Newborns; Pediatrics; Saliva

Indexed keywords

EID: 85032373809     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/FPUBH.2017.00083     Document Type: Short Survey

References (113)

1. Benito J, Acedo Y, Medrano L, Barcena E, Garay RP, Arri EA. Usefulness of new and traditional serum biomarkers in children with suspected appendicitis. Am J Emerg Med (2016) 34:871-6. doi:10.1016/j.ajem.2016.02.011
2. Wang H, Hu J, Chen L. Decreased serum miR-503 level in children with nephrotic syndrome. Clin Lab (2015) 61:1917-26. doi:10.7754/Clin.Lab.2015.150407
3. Odera G, Vaira D, Holton J, Dowsett JF, Ansaldi N. Serum pepsinogen I and IgG antibody to Camplylobacter pylori in non-specific abdominal pain in childhood. Gut (1989) 30:912-6. doi:10.1136/gut.30.7.912
4. Scheuring U, Skopnik H, Roth B, Uhlenbruck G, Metzgar RS. Analysis of pancreatic serum markers in patients with cystic fibrosis. Pancreas (1991) 6:229-33. doi:10.1097/00006676-199103000-00016
5. Keane M, Fallon R, Riordan A, Shaw B. Markedly raised levels of C-reactive protein are associated with culture-proven sepsis or necrotizing enterocolitis in extremely preterm neonates. Acta Paediatr (2015) 104:e289-93. doi:10.1111/apa.12978
6. Hedegaard SS, Wisborg K, Hvas AM. Diagnostic utility of biomarkers for neonatal sepsis-a systematic review. Infect Dis (2015) 47:117-24. doi:10.3109/00365548.2014.971053
7. Zahng Y, Sun J, Lin CC, Abemayor E, Wang MB, Wong DT. The emerging landscape of salivary diagnostics. Peridontol 2000 (2016) 70:38-52. doi:10.1111/prd.12099
8. Bonne NJ, Wong DT. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med (2012) 4:82. doi:10.1186/gm383
9. Schafer CA, Schafer JJ, Yakob M, Lima P, Camargo P, Wong DT. Saliva diagnostics: utilizing oral fluids to determine health status. Monogr Oral Sci (2014) 24:88-98. doi:10.1159/000358791
10. Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res (2016) 6:66-75. doi:10.1016/j.jobcr.2015.08.006
11. Nunes LA, Mussavira S, Bindhu OS. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid. Biochem Med (2015) 5:177-92. doi:10.11613/BM.2015.018
12. Ranger M, Grunau RE. Early repetitive pain in preterm infants in relation to the developing brain. Pain Manag (2014) 4:57-67. doi:10.2217/pmt.13.61
13. Vinall J, Grunau RE. Impact of repeated procedural pain-related stress in infants born very preterm. Pediatr Res (2014) 75:584-7. doi:10.1038/pr.2014.16
14. Institute of Medicine (US) Committee on Clinical Research Involving Children, Field MJ, Behrman RE, editors. Ethical Conduct of Clinical Research Involving Children. Washington, DC: National Academies Press (2004). 2, The Necessity and Challenges of Clinical Research Involving Children. Available from: http://www.ncbi.nlm.nih.gov/books/NBK25553/
15. Autmizguine J, Benjamin DK Jr, Smith PB, Sampson M, Overchkine P, Cohen-Wolkowiez M, et al. Pharmacokinetic studies in infants using minimal-risk study designs. Curr Clin Pharmacol (2014) 9:350-8. doi:10.2174/1574884709666140520153308
16. U.S. Food and Drug Administration. Additional Protections for Children. (2001). Available from: http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ucm119111.htm
17. Baum BJ, Yates JR III, Srivastava S, Wong DT, Melvin JE. Scientific frontiers: emerging technologies for salivary diagnostics. Adv Dent Res (2011) 23:360-8. doi:10.1177/0022034511420433
18. Hart RW, Mauk MG, Liu C, Qiu X, Thompson JA, Chen D, et al. Point-of-care oral-based diagnostics. Oral Dis (2011) 17:745-52. doi:10.1111/j.1601-0825.2011.01808.x
19. Wong DT. Salivomics. J Am Dent Assoc (2012) 143:19S-24S. doi:10.14219/jada.archive.2012.0339
20. Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent (2009) 22:241-8.
21. Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ (2008) 12(Suppl 1):22-9. doi:10.1111/j.1600-0579.2007.00477.x
22. Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent (2001) 85:162-9. doi:10.1067/mpr.2001.113778
23. Carpenter GH. The secretion, components, and properties of saliva. Annu Rev Food Sci Technol (2013) 4:267-76. doi:10.1146/annurev-food-030212-182700
24. Drobitch RK, Svensson CK. Therapeutic drug monitoring in saliva: an update. Clin Pharmacokinet (1992) 23:365-79. doi:10.2165/00003088-199223050-00003
25. Ben-Aryeh H, Fisher M, Szargel R, Laufer D. Composition of whole unstimulated saliva of healthy children: changes with age. Arch Oral Biol (1990) 35:929-31. doi:10.1016/0003-9969(90)90075-L
26. Salvolini E, Mazzanti L, Martarelli D, Di Giorgio R, Fratto G, Curatola G. Changes in the composition of human unstimulated whole saliva with age. Aging (1999) 11:119-22.
27. Redman RS. Development of the salivary glands. In: Sreebny LM, editor. The Salivary System. Boca Raton, FL: CRC Press (1987). p. 2-17.
28. Sevenhuysen GP, Holodinsky C, Dawes C. Development of salivary a-amylase in infants from birth to 5 months. Am J Clin Nutr (1984) 39:584-8.
29. Rossiter MA, Barrowman JA, Dand A, Wharton BA. Amylase content of mixed saliva in children. Acta Paediatr Scand (1974) 63:389-92. doi:10.1111/j.1651-2227.1974.tb04815.x
30. Yang Z-M, Chen L-H, Zhang M, Lin J, Zhang J, Chen WW, et al. Age differences of salivary alpha-amylase levels of basal and acute responses to citric acid stimulation between Chinese children and adults. Front Physiol (2015) 6:340. doi:10.3389/fphys.2015.00340
31. Chen LH, Yang ZM, Chen WW, Lin J, Zhang M, Yang XR, et al. Attenuated acute salivary a-amylase responses to gustatory stimulation with citric acid in thin children. Br J Nutr (2015) 113:1078-85. doi:10.1017/S0007114515000446
32. Castagnola M, Inzitari R, Fanali C, Iavarone F, Vitali A, Desiderio C, et al. The surprising composition of the salivary proteome of preterm human newborn. Mol Cell Proteomics (2011) 10:M110.003467. doi:10.1074/mcp.M110.003467
33. Nuriel-Ohayon M, Neuman H, Koren O. Microbial changes during pregnancy, birth, and infancy. Front Microbiol (2016) 7:1031. doi:10.3389/fmicb.2016.01031
34. Rautava S. Early microbial contact, the breast milk microbiome and child health. J Dev Orig Health Dis (2016) 7:5-14. doi:10.1017/S2040174415001233
35. Munyaka PM, Khafipour E, Ghia JE. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr (2014) 2:109. doi:10.3389/fped.2014.00109
36. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 107:11971-5. doi:10.1073/pnas.1002601107
37. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr (1999) 28:19-25. doi:10.1097/00005176-199901000-00007
38. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3:e3056. doi:10.1371/journal.pone.0003056
39. Morzel M, Jeannin A, Lucchi G, Truntzer C, Pecqueur D, Nicklaus S, et al. Human infant saliva peptidome is modified with age and diet transition. J Proteomics (2012) 75:3665-73. doi:10.1016/j.jprot.2012.04.028
40. Morzel M, Palicki O, Chabanet C, Lucchi G, Ducoroy P, Chambon C, et al. Saliva electrophoretic protein profiles in infants: changes with age and impact of teeth eruption and diet transition. Arch Oral Biol (2011) 56:634-42. doi:10.1016/j.archoralbio.2010.12.015
41. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol (1997) 2:123-37. doi:10.1902/annals.1997.2.1.123
42. Adriaanse MP, Vreugdenhil AC, Vastmans V, Groeneveld L, Molenbroeck S, Schott DA. Human leukocyte antigen typing using buccal swabs as accurate and non-invasive substitute for venipuncture in children at risk for celiac disease. J Gastroenterol Hepatol (2016) 31:1711-16. doi:10.1111/jgh.13331
43. Witsø E, Stene LC, Paltiel L, Joner G, Rønningen KS. DNA extraction and HLA genotyping using mailed mouth brushes from children. Pediatr Diabetes (2002) 3:89-94. doi:10.1034/j.1399-5448.2002.30205.x
44. Vandewoestyne M, Van Hoofstat D, Franssen A, Van Nieuwerburgh F, Deforce D. Presence and potential of cell free DNA in different types of forensic samples. Forensic Sci Int Genet (2013) 7:316-20. doi:10.1016/j.fsigen.2012.12.005
45. Yao W, Mei C, Nan X, Hui L. Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study. Gene (2016) 15:142-8. doi:10.1016/j.gene.2016.06.033
46. Tu M, Wei F, Yang J, Wong D. Detection of exosomal biomarker by electric field-induced release and measurement (ERIFM). J Vis Exp (2015) 95:52439. doi:10.3791/52439
47. Oxnard GR, Paweletz CP, Sholl LM. Genomic analysis of plasma cell-free DNA in patients with cancer. JAMA Oncol (2016). doi:10.1001/jamaoncol.2016.2835
48. Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: a pilot study. Thorac Cancer (2016) 7:428-38. doi:10.1111/1759-7714.12350
49. Maron JL, Johnson KL, Rocke DM, Cohen MG, Liley AJ, Bianchi DW. Neonatal salivary analysis reveals global developmental gene expression changes in the premature infant. Clin Chem (2010) 56:409-16. doi:10.1373/clinchem.2009.136234
50. Maron JL. The neonatal transcriptome. Cold Spring Harb Perspect Med (2015) 6:a026369. doi:10.1101/cshperspect.a026369
51. Maron JL. Exploring the neonatal salivary transcriptome: technical optimization and clinical applications. Clin Biochem (2011) 44:467-8. doi:10.1016/j.clinbiochem.2011.03.019
52. Maron JL, Hwang JS, Pathak S, Ruthazer R, Russell RL, Alterovtiz G. Computational gene expression modeling identifies salivary biomarker analysis that predict oral feeding readiness in the newborn. J Pediatr (2014) 166:282-8. doi:10.1016/j.jpeds.2014.10.065
53. Maron JL, Johnson KL, Dietz JA, Chen ML, Bianchi DW. Neuropepetide Y2 receptor (NPY2R) expression in saliva predicts feeding immaturity in the premature neonate. PLoS One (2012) 7:e37870. doi:10.1371/journal.pone.0037870
54. Zimmerman E, Maki M, Maron J. Salivary FOXP2 expression and oral feeding success in premature infants. Cold Spring Harb Mol Case Stud (2016) 2:a000554. doi:10.1101/mcs.a000554
55. Zimmerman E, Maron JL. FOXP2 gene deletion and infant feeding difficulties: a case report. Cold Spring Harb Mol Case Stud (2016) 2:a000547. doi:10.1101/mcsa000547
56. Amado F, Lobo MJ, Domingues P, Duarte JA, Vitorino R. Salivary peptidomics. Expert Rev Proteomics (2010) 7(5):709-21. doi:10.1586/epr.10.48
57. Wei F, Wong DT. Point-of-care platforms for salivary diagnostics. Chin J Dent Res (2012) 15:7-15.
58. Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis (2011) 17:345-54. doi:10.1111/j.1601-0825.2010.01773.x
59. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc (2006) 137:313-21. doi:10.14219/jada.archive.2006.0180
60. Pasic MD, Yousef GM, Diamandis EP. The proteomic revolution in laboratory medicine. Clin Biochem (2013) 6:397-8. doi:10.1016/j.clinbiochem.2013.02.012
61. Amado FM, Vitorino RM, Domingues PM, Lobo MJ, Duarte JA. Analysis of the human saliva proteome. Expert Rev Proteomics (2005) 2:521-39. doi:10.1586/14789450.2.4.521
62. Schulz BL, Cooper-White J, Punyadeera CK. Saliva proteome research: current status and future outlook. Crit Rev Biotechnol (2013) 33:246-59. doi:10.3109/07388551.2012.687361
63. Hu S, Loo JA, Wong DT. Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics (2007) 4:531-8. doi:10.1586/14789450.4.4.531
64. John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 130:929-35. doi:10.1001/archotol.130.8.929
65. Mishra S, Saadat D, Kwon O, Lee Y, Choi WS, Kim JH, et al. Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics. Biosens Bioelectron (2016) 81:181-97. doi:10.1016/j.bios.2016.02.040
66. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 56:3588-600. doi:10.1002/art.22954
67. Rahim MA, Rahim ZH, Ahmad WA, Hashim OH. Can saliva proteins be used to predict the onset of acute myocardial infarction among high-risk patients. Int J Med Sci (2015) 12:329-35. doi:10.7150/ijms.11280
68. Nicholas BL, Skipp P, Barton S, Singh D, Bagmane D, Mould R, et al. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 181:1049-60. doi:10.1164/rccm.200906-0857OC
69. Hirtz C, Chevalier F, Sommerer N, Raingeard I, Bringer J, Rossignol M, et al. Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry. Clin Proteomics (2006) 2:117-27. doi:10.1385/CP:2:1:117
70. Cabras T, Pisano E, Boi R, Olianas A, Manconi B, Inzitari R, et al. Age-dependent modifications of the human salivary secretory protein complex. J Proteome Res (2009) 8:4126-34. doi:10.1021/pr900212u
71. Nayak S, Bhad WA, Doshi UH. The relationship between salivary insulin-like growth factor I and quantitative cervical maturational stages of skeletal maturity. J Orthod (2014) 41:170-4. doi:10.1179/1465313313Y.0000000091
72. Messana I, Cabras T, Iavarone F, Manconi B, Huang L, Martelli C, et al. Chrono-proteomics of human saliva: variations of the salivary proteome during human development. J Proteome Res (2015) 14:1666-77. doi:10.1021/pr501270x
73. Fonteles CS, dos Santos CF, da Silva Alves KS, de Miranda Mota AC, Damasceno JX, Fonteles MC. Comparative proteomic analysis of human whole saliva of children with protein-energy undernutrition. Nutrition (2012) 28:744-8. doi:10.1016/j.nut.2011.10.005
74. Shi P, Goodson JM, Hartman ML, Hasturk H, Yaskell T, Vargas J, et al. Continuous metabolic syndrome scores for children using salivary biomarkers. PLoS One (2015) 10:e0138979. doi:10.1371/journal.pone.0138979
75. Abikshyeet P, Ramesh V, Oza N. Glucose estimation in the salivary secretion of diabetes mellitus patients. Diabetes Metab Syndr Obes (2012) 5:149-54. doi:10.2147/DMSO.S32112
76. Agrawal RP, Sharma N, Rathore MS, Gupta VB, Jain S, Agarwal V, et al. Non-invasive method for glucose level estimation by saliva. J Diabetes Metab (2013) 4:1-5. doi:10.4172/2155-6156
77. Twetman S, Nederfors T, Stahl B, Aronson S. Two-year longitudinal observations of salivary status and dental caries in children with insulin-dependent diabetes mellitus. Pediatr Dent (1992) 14:184-8.
78. Kadashetti V, Baad R, Malik N, Shivakumar KM, Vibhute N, Belgaumi U, et al. Glucose level estimation in diabetes mellitus by saliva: a bloodless revolution. Rom J Intern Med (2015) 53:248-52. doi:10.1515/rjim-2015-0032
79. Abrão AL, Falcao DP, de Amorim RF, Bezerra AC, Pombeiro GA, Guimarães LJ, et al. Salivary proteomics: a new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus. Med Hypotheses (2016) 89:97-100. doi:10.1016/j.mehy.2016.02.010
80. Castagnola M, Messana I, Inzitari R, Fanali C, Cabras T, Morelli A, et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J Proteome Res (2008) 7:5327-32. doi:10.1021/pr8004088
81. Ngounou Wetie AG, Wormwood KL, Russell S, Ryan JP, Darie CC, Woods AG. A pilot proteomic analysis of salivary biomarkers in autism spectrum disorder. Autism Res (2015) 8:338-50. doi:10.1002/aur.1450
82. Wormwood KL, Aslebagh R, Channaveerappa D, Dupree EJ, Borland MM, Ryan JP, et al. Salivary proteomics and biomarkers in neurology and psychiatry. Proteomics Clin Appl (2015) 9:899-906. doi:10.1002/prca.201400153
83. WHO Fact Sheet. Children: Reducing Mortality (2016). Available from: https://www.who.int/mediacentre/factsheets/fs178/en/
84. Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. Exploring the oral bacterial flora: current status and future directions. Oral Dis (2010) 16:136-45. doi:10.1111/j.1601-0825.2009.01607.x
85. Lif Holgerson P, öhman C, Rönnlund A, Johansson I. Maturation of oral microbiota in children with or without dental caries. PLoS One (2015) 10:e0128534. doi:10.1371/journal.pone.0128534
86. Fabian TK, Fejerdy P, Csermely P. Salivary genomics, transcriptomics, and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr Genomics (2008) 9:11-21. doi:10.2174/138920208783884900
87. Sueki A, Matsuda K, Yamaguchi A, Uehara M, Sugano M, Uehara T, et al. Evaluation of saliva as diagnostic materials for influenza virus infection by PCR-based assays. Clin Chim Acta (2015) 453:71-4. doi:10.1016/j.cca.2015.12.006
88. Martin ET, Kuypers J, McRoberts JP, Englund JA, Zerr DM. Human bocavirus-1 primary infection and shedding in infants. J Infect Dis (2015) 212:516-24. doi:10.1093/infdis/jiv044
89. de França TR, Carvalho AD, Gomes VB, Gueiros LA, Porter SR, Leao JC. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. Clin Oral Investig (2012) 16:659-64. doi:10.1007/s00784-011-0548-5
90. Cannon MJ, Stowell JD, Clark R, Dollard PR, Johnson D, Mask K, et al. Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis (2014) 14:569. doi:10.1186/s12879-014-0569-1
91. Yamamoto Y, Morooka M, Hashimoto S, Ihra M, Yoshikawa T. Analysis of the shedding of three ß-herpesviruses in urine and saliva of children with renal disease. J Med Virol (2014) 86:505-11. doi:10.1002/jmv.23782
92. Smith RJH, Shearer AE, Hildebrand MS, Camp GV. Deafness and hereditary hearing loss overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews®.Seattle, WA: University of Washington (1999). Available from: http://www.ncbi.nlm.nih.gov/books/NBK1434/
93. Stern H, Tucker SM. Cytomegalovirus infection in the newborn and in early childhood. Lancet (1965) 2:1268-71. doi:10.1016/S0140-6736(65)92283-X
94. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sánchez PJ, Bernstein DI, et al. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis (2014) 210:1415-8. doi:10.1093/infdis/jiu263
95. Barzon L, Pacenti M, Berto A, Sinigaglia A, Franchin E, Lavezzo E, et al. Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016. Euro Surveill (2016) 21(10):30159. doi:10.2807/1560-7917.ES.2016.21.10.30159
96. Barzon L, Pacenti M, Berto A, Sinigaglia A, Franchin E, Lavezzo E, et al. Detection of Zika virus in saliva. J Clin Virol (2015) 68:53-5. doi:10.1016/j.jcv.2015.04.021
97. Brandrzaeg P. Synthesis and secretion of human salivary immunoglobulins. In: Garrett JR, Ekström J, Anderson LC, editors. Glandular Mechanisms of Salivary Secretion: Frontiers of Oral Biology. (Vol. 10), Basel: Karger (1998). p. 167-99.
98. Jayashree S, Bhan MK, Kumar R, Raj P, Glass R, Bhandari N. Serum and salivary antibodies as indicators of rotavirus infection in neonates. J Infect Dis (1988) 158:1117-20. doi:10.1093/infdis/158.5.1117
99. Friedman MG, Segal B, Zedaka R, Sarov B, Margalith M, Bishop R, et al. Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns. Clin Exp Immunol (1993) 92:194-9. doi:10.1111/j.1365-2249.1993.tb03379.x
100. Eckstein MB, Brown DW, Foster A, Richards AF, Gilbert CE, Vijayalakshmi P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ (1996) 312:161. doi:10.1136/bmj.312.7024.161
101. Spicher VM, Bouvier P, Schlegel-Haueter SE, Morabia A, Siegrist CA. Epidemiology of herpes simplex virus in children by detection of specific antibodies in saliva. Pediatr Infect Dis J (2001) 20:265-72. doi:10.1097/00006454-200103000-00010
102. Vainio K, Samdal HH, Ånestad G, Wedege E, Skutlaberg DH, Bransdal KT, et al. Detection of measles-and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Eur J Clin Microbiol Infect Dis (2008) 27:461-5. doi:10.1007/s10096-008-0460-3
103. Arora G, Sheikh S, Pallagatti S, Singh B, Singh VA, Singh R. Saliva as a tool in the detection of hepatitis B surface antigen in patients. Compend Contin Educ Dent (2012) 33:174-6.
104. Archibald DW, Johnson JP, Nair P, Alger LS, Hebert CA, Davis E, et al. Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children. AIDS (1990) 4:417-20. doi:10.1097/00002030-199005000-00006
105. Zaka-ur-Rab Z, Abqari S, Shahab T, Islam N, Shukla I. Evaluation of salivary anti-Salmonella typhi lipopolysaccharide IgA ELISA for serodiagnosis of typhoid fever in children. Arch Dis Child (2012) 97:236-8. doi:10.1136/adc.2011.300622
106. Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, Romero H, Simón-Soro A, Pignatelli M, et al. The oral metagenome in health and disease. ISME J (2012) 6:46-56. doi:10.1038/ismej.2011.85
107. Wade WG. Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease? J Clin Periodontol (2011) 38(Suppl 11):7-16. doi:10.1111/j.1600-051X.2010.01679.x
108. Centers for Disease Control. Health, United States, 2015 with Special Feature on Racial and Ethnic Health Disparities. Available from: https://www.cdc.gov/nchs/data/hus/hus15.pdf
109. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem (2009) 55:1910-31. doi:10.1373/clinchem.2008.108670
110. Guinan T, Ronci M, Kobus H, Voelcker NH. Rapid detection of illicit drugs in neat saliva using desorption/ionization on porous silicon. Talanta (2003) 99:791-8. doi:10.1016/j.talanta.2012.07.029
111. Cámpora P, Bermejo AM, Tabernero MJ, Fernandez P. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS). J Anal Toxicol (2003) 27:270-4. doi:10.1093/jat/27.5.270
112. Fisher DS, Patridge SJ, Handley SA, Couchman L, Morgan PE, Flanagan RJ. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci Int (2013) 229:145-50. doi:10.1016/j.forsciint.2013.03.021
113. Sood SP, Green VI, Vieva LL. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. VI: a rapid microscale method for determination of caffeine in plasma and saliva. Ther Drug Monit (1989) 11:361-4. doi:10.1097/00007691-198905000-00023